# Optimal Dextrose Concentration for Prolotherapy in Tendinopathy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials > Sahlan A. URL kanonis: https://discover.unhas.ac.id/publications/pub_scopus_105055815105 Jurnal / Konferensi: Archives of Physical Medicine and Rehabilitation Tahun terbit: 2026 DOI: https://doi.org/10.1016/j.apmr.2026.10.004 ISSN: 00039993 Kuartil SJR: Q1 Citations: 0 ## Authors - Sahlan A. ## Abstract OBJECTIVE: To compare the effectiveness of different dextrose concentrations used in prolotherapy to reduce pain in patients with tendinopathy. DATA SOURCES: PubMed, Cochrane Library, and SciceDirecere searched from inception through July 2025. STUDY SELECTION: Randomized controlled trials of dextrose prolotherapy for tendinopathy were included; trials reporting 0-10 pain scores at 6-12 weeks compared with saline were eligible for network meta-analysis. DATA EXTRACTION: Two reviewers independently extracted data and assessed risk of bias using the Cochrane Risk of Bias 2.0 tool; the certainty of the evidence was rated using the Confidence in Network Meta-Analysis framework. DATA SYNTHESIS: A frequentist common-effect network meta-analysis estimated mean differences (MDs) with 95% CIs relative to saline, and these were interpreted against a minimal clinically important difference of 1.4 points. Nine Randomized controlled trials (490 participants) were included; 6 were at low risk of bias, and 3 had some concerns. Three trials (111 participants) formed the network, with each comparison based on a single trial. Compared with saline, 15% dextrose (MD=-4.66; 95% CI, -5.36 to -3.96) and 5% dextrose (MD=-3.55; 95% CI, -4.24 to -2.86) reduced pain beyond the minimal clinically important difference; both estimates came from a single 3-arm lateral epicondylitis trial, in which 15% dextrose exceeded 5% by 1.11 points (95% CI, 0.43-1.79). Neither 20% dextrose (MD=0.26; 95% CI, -0.22 to 0.74) nor 10.7% dextrose-morrhuate (MD=-0.30; 95% CI, -1.23 to 0.63) differed from saline. Heterogeneity and inconsistency could not be assessed, and the certainty of the evidence was rated as low to very low. CONCLUSIONS: Evidence on the optimal dextrose concentration for tendinopathy is limited. The apparent advantage of 5% and 15% dextrose is based on a single trial and may reflect differences in tendon site, injection schedule, and follow-up rather than concentration alone. Adequately powered trials directly comparing concentrations are needed before dosing recommendations can be made. ## Keywords - Medicine - Prolotherapy - Randomized controlled trial - Tendinopathy - Confidence interval - Physical therapy - Placebo - Clinical trial - Relative risk - Meta-analysis - Anesthesia - Minimal clinically important difference - MEDLINE - Osteoarthritis - Surgery - Saline - Randomization - Data extraction - Frequentist inference --- Sumber: Discover Unhas — RIMS Universitas Hasanuddin. Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.